These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8323738)

  • 1. Screening for cancer of the uterine cervix in Greenland.
    Nielsen NH; Jensen H
    APMIS; 1993 Apr; 101(4):290-4. PubMed ID: 8323738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
    Macgregor JE; Campbell MK; Mann EM; Swanson KY
    BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial screening for cervical carcinoma in Praestø Amt 1972-1975.
    Berget A; Olsen J; Poll P
    Dan Med Bull; 1978 Dec; 25(6):230-2. PubMed ID: 720143
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancers in Greenlandic women diagnosed after negative results on cervical cytology: perspectives in a high-risk population.
    Nielsen NH; Jensen H
    APMIS; 1993 Jun; 101(6):492-6. PubMed ID: 8363826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of the uterine cervix and dysplasia in Greenland.
    Nielsen NH; Mikkelsen F; Hansen JP
    Acta Pathol Microbiol Scand A; 1978 Jan; 86(1):36-44. PubMed ID: 636887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
    van Oortmarssen GJ; Habbema JD
    Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynaecological cytology screening in South Australia: a 23-year experience.
    MacCormac L; Lew W; King G; Allen PW
    Med J Aust; 1988 Nov; 149(10):530-6. PubMed ID: 3185322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of dysplasia, carcinoma in situ and invasive carcinoma in colposcopic findings of atypical re-epithelization zone (A.R.Z.) and atypical transformation zone (A.T.Z.).
    De Punzio C; Fiore N; Vecoli LE; Rosi F; Teti G
    Eur J Gynaecol Oncol; 1985; 6(1):57-61. PubMed ID: 3971996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience in screening for cervical cancer in rural areas of Barsi Tehsil (Maharashtra).
    Nene BM; Jayant K; Malvi SG; Dale PS; Deshpande R
    Indian J Cancer; 1994 Mar; 31(1):34-40. PubMed ID: 8063335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [False negative Pap smears in a Danish material].
    Ejersbo D; Dahl MB; Hølund B
    Ugeskr Laeger; 2003 Jun; 165(23):2391-4. PubMed ID: 12840998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cervical cancer in Butha Buthe, Lesotho. A study of Papanicolaou (Pap) smears in a previously unscreened community over a one-year period.
    Schneider A; Meinhardt G
    Trop Doct; 1984 Oct; 14(4):170-4. PubMed ID: 6495377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic screening for cervical cancer in southern Iran.
    Behmard S; Taherzadeh D; Gondos B
    Acta Cytol; 1977; 21(3):432-4. PubMed ID: 268125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papanicolaou smear screening augmented by a magnified chemiluminescent exam.
    Mann W; Lonky N; Massad S; Scotti R; Blanco J; Vasilev S
    Int J Gynaecol Obstet; 1993 Dec; 43(3):289-96. PubMed ID: 7907040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysplasia and carcinoma in situ of the uterine cervix: prevalence in very young women (under age 22). A one-year study in a health plan population.
    Snyder RN; Ortiz Y; Willie S; Cove JK
    Am J Obstet Gynecol; 1976 Apr; 124(7):751-6. PubMed ID: 1258935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of gynaecological abnormalities in pre-selection criteria for cervical screening: preliminary evaluation of 3602 subjects in south India.
    Sujathan K; Kannan S; Pillai KR; Mathew A; Joseph M; Symalakumari B; Nair MK
    Cytopathology; 1995 Apr; 6(2):75-87. PubMed ID: 7795168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cytology in Zambia.
    Grech ES; O'Dowd MJ; Tsirkina GA; Zeigler O
    Med J Zambia; 1977; 11(4):112-7. PubMed ID: 919781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a colpocytologic mass screening and in-patient casework: comparison by age groups.
    Canevini P; Spinelli M; Fibbi L
    Tumori; 1977; 63(6):575-84. PubMed ID: 601885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.